Propanc Biopharma, Inc. (PPCB)
NASDAQ: PPCB · Real-Time Price · USD
0.1916
-0.0111 (-5.48%)
At close: Feb 20, 2026, 4:00 PM EST
0.1901
-0.0015 (-0.78%)
After-hours: Feb 20, 2026, 7:50 PM EST

Propanc Biopharma Balance Sheet

Millions USD. Fiscal year is Jul - Jun.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Jun '25 Jun '24 Jun '23 Jun '22 Jun '21
Cash & Equivalents
0.560.010.020.0100
Cash & Short-Term Investments
0.560.010.020.0100
Cash Growth
3735.42%-42.67%109.86%147.04%80.36%-96.64%
Other Receivables
0.020.010000
Receivables
0.020.010000
Prepaid Expenses
7.138.33-0.010.01-
Other Current Assets
000---
Total Current Assets
7.718.350.030.020.020.01
Property, Plant & Equipment
0.060.060.020.040.060
Long-Term Deferred Charges
-0.290.03---
Other Long-Term Assets
7.3510.930000
Total Assets
15.1119.630.070.060.080.01
Accounts Payable
0.961.251.210.970.941
Accrued Expenses
1.732.351.531.210.941.31
Short-Term Debt
0.591.560.870.510.980.68
Current Portion of Leases
0.020.020.020.020.02-
Other Current Liabilities
0.320.40.160.450.180.09
Total Current Liabilities
3.625.583.793.163.063.08
Long-Term Debt
-0.110.06---
Long-Term Leases
0.040.04-0.020.04-
Total Liabilities
3.665.733.853.183.113.08
Common Stock
0.010.0100.0100.01
Additional Paid-In Capital
143.64138.2461.760.3157.3654.07
Retained Earnings
-134.48-125.62-66.7-64.68-61.56-58.2
Treasury Stock
-0.05-0.05-0.05-0.05-0.05-0.05
Comprehensive Income & Other
1.331.321.271.291.211.09
Total Common Equity
10.4513.91-3.78-3.12-3.03-3.07
Shareholders' Equity
11.4513.91-3.78-3.12-3.02-3.07
Total Liabilities & Equity
15.1119.630.070.060.080.01
Total Debt
0.651.730.950.551.040.68
Net Cash (Debt)
-0.09-1.71-0.93-0.54-1.04-0.68
Net Cash Per Share
-0.01-0.43----
Filing Date Shares Outstanding
15.8612.810.01---
Total Common Shares Outstanding
13.4511.61----
Working Capital
4.082.77-3.77-3.14-3.05-3.07
Book Value Per Share
0.781.20----
Tangible Book Value
10.4513.91-3.78-3.12-3.03-3.07
Tangible Book Value Per Share
0.781.20----
Machinery
0.03--0.030.030.03
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.